Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.

European heart journal - 1 Nov 1995

Raynolds M V, Perryman M B

Abstract excerpt

The cardiac vasculature and myocardium contain components of the renin-angiotensin system (RAS), which may regulate local growth and cellular function. Alterations in the expression or action of these components, which include angiotensin converting enzyme (ACE), angiotensinogen, and angiotensin II type-1 receptors, may contribute to the development of disease, such as hypertension, left ventricular hypertrophy,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin II
Share to Angiotensinogen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomegaly

Share to ACE gene

Share to Genetic Variation

Share to Peptidyl-Dipeptidase A

Share to Receptors, Angiotensin

Share to Renin-Angiotensin System

Source

Identifiers

PMID: 8869132
DOI: 10.1093/eurheartj/16.suppl_k.23

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.PMID 8869132Read ↗

Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system.Semantic proximity Read ↗

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.Semantic proximity Read ↗

Genetics and pharmacogenetics in heart failure.Semantic proximity Read ↗

Pharmacogenetics of heart failure.Semantic proximity Read ↗

Genetic polymorphisms of the natriuretic peptide system in the pathogenesis of cardiovascular disease: what lies on the horizon?Semantic proximity Read ↗

Heart failure and personalized medicine.Semantic proximity Read ↗

Pharmacogenomics in cardiac therapy: Personalizing treatment for heart healthSemantic proximity Read ↗

State of play of pharmacogenetics and personalized medicine in heart failure.Semantic proximity Read ↗

Molecular biology and genetics of the angiotensin-I-converting enzyme: potential implications in cardiovascular diseasesSemantic proximity Read ↗

Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.Semantic proximity Read ↗

Genetic Markers of Cardiovascular Disease.Semantic proximity Read ↗

Genetics of common forms of heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.